References
- SillesenMHjortdalVVejlstrupNSørensenKPregnancy with prosthetic heart valves – 30 years’ nationwide experience in DenmarkEur J Cardiothorac Surg201140244845421277217
- Iturbe-AlessioIFonsecaMCMutchinikOSantosMAZajaríasASalazarERisks of anticoagulant therapy in pregnant women with artificial heart valvesN Engl J Med198631522139013933773964
- HungLRahimtoolaSHProsthetic heart valves and pregnancyCirculation200310791240124612628941
- ElkayamUSinghHIraniAAkhterMWAnticoagulation in pregnant women with prosthetic heart valvesJ Cardiovasc Pharmacol Ther20049210711515309247
- American College of CardiologyAmerican College of Cardiology/American Heart Association American Heart Association2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Thorac Cardiovasc Surg20141481e1e13224939033
- McLintockCMcCowanLMNorthRAMaternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparinBJOG2009116121585159219681850
- SnapeEThachilJClarkeBVauseSAnti-Xa based dose changes during low molecular weight heparin anticoagulation for mechanical prosthetic heart valves during pregnancyJ Obstet Gynaecol201838572172229436886
- JamesACommittee on Practice Bulletins–ObstetricsPractice bulletin no. 123: thromboembolism in pregnancyObstet Gynecol201111871872921860313
- FreedmanRABauerKANeubergDSZwickerJITiming of postpartum enoxaparin administration and severe postpartum hemorrhageBlood Coagul Fibrinolysis2008191555918180616
- VauseSClarkeBTowerCLHayCKnightM(on behalf of UKOSS). Pregnancy outcomes in women with mechanical prosthetic heart valves: a prospective descriptive population based study using the United Kingdom Obstetric Surveillance System (UKOSS) data collection systemBJOG201712491411141928019065
- VauseSClarkeBTowerCHayCKnightMMechanical prosthetic heart valves (MPHV) in pregnancy are associated with a high risk of maternal and fetal morbidity and mortalityHeart2017103191557
- SadlerLMcCowanLWhiteHStewartABrackenMNorthRPregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valvesBJOG2000107224525310688509
- FoxNSLaughonSKBenderSDSaltzmanDHRebarberAAnti-factor Xa plasma levels in pregnant women receiving low molecular weight heparin thromboprophylaxisObstet Gynecol2008112488488918827132
- SephtonVFarquharsonRGToppingJA longitudinal study of maternal dose response to low molecular weight heparin in pregnancyObstet Gynecol200310161307131112798541
- European Society of Gynecology (ESG) Association for European Paediatric Cardiology (AEPC) German Society for Gender Medicine (DGesGM)ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)Eur Heart J201132243147319721873418
- SteinbergZLDominguez-IslasCPOttoCMStoutKKKriegerEVMaternal and fetal outcomes of anticoagulation in pregnant women with mechanical heart valvesJ Am Coll Cardiol201769222681269128571631
- NishimuraRAOttoCMBonowRO2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on clinical practice guidelinesJ Am Coll Cardiol201770225228928315732